European Leukemia Trial Registry

More Details
Title Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of PV Symptoms
Scientific Title Polycythemia Vera Symptom Study Evaluating Ruxolitinib Versus Hydroxyurea in a Randomized, Multicenter, Double-Blind, Double-Dummy, Phase 3 Efficacy and Safety Study of Patient Reported Outcomes
Short Title RELIEF
Trialgroup NN
Type of Trial multicentric, randomized, prospective, double-blind, double-group
Disease Myeloproliferative disease(MPD) Polycythaemia vera
Age >= 18 years
Status Closed
Start of Recruitment 01.06.2012
Leader Griesshammer, Prof. Dr. med., Martin
Shortprotocol Shortprotocol
created 10.04.2013 Johannes Kraus
changed 20.12.2013 Hanna Ebert
ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | |